RE:RE:RE:RE:RE:RE:RE:RE:More downward pressuremonty613 wrote:
1. how on earth would they make profits selling at $3.50? $94MM of the purchase via share consideration was at a deemed price of $9.80 per share. the breakdown of the transaction consideration, including the # of shares issued to the MyHealth vendors, is public. go look.
I did look and the math is pretty simple. If their cost base prior to the acquisition was (say) $0.10 for each WELL share equivalent, they are still doing well. You are confusing the price they received with their actual cost base. If you bought WELL at $0.50 and then WELL was sold for $10, then the acquirer dropped to $5 on a per share equivalent basis, you still make money.
monty613 wrote:
2. MyHealth took share consideration knowing the growth scenario is a longer hold than <1 year. otherwise, they would have taken the cash offer(s). yes, there were multiple offers.
Unless you were "in the room", how do you know that? Maybe the next best deal was $120 million all cash and they decided to take the WELL deal.
monty613 wrote:
3. MyHealth did not and does not have such shareholders.
How do you know their shareholder base?
monty613 wrote:
4. no one knows - but I can still offer my opinion and insights as to why I think you and the OP are wrong? get a grip and realize we are allowed to debate here.
That's kinda the point and we are debating!